Reliance Infra to receive Rs 1,100 cr equity infusion from promoters

Q: How long will it take to read this news story?

The story "Reliance Infra to receive Rs 1,100 cr equity infusion from promoters" has 379 words across 16 sentences, which will take approximately 2 - 4 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Reliance Infra to receive Rs 1,100 cr equity infusion from promoters" was covered 1 weeks ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 298 news stories per day. It's most recent story was published 3 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Negative, indicating that people regard this as "bad news".

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #22617372</li><li>URL: https://beamstart.com/news/reliance-infra-to-receive-rs-17268166662617</li></ul>

Business Standard Logo Business Standard 1w ago

Reliance Infra to receive Rs 1,100 cr equity infusion from promoters - Business Standard

Quick Summary:

In the first phase, the company is launching Rs 3,014 crore preferential placement under which 12.56 crore equity shares or convertible warrants will be issued at an issue price of Rs 240 per share, according to the company's postal ballot seeking shareholder nod for share issue.

The board of the company had on Thursday approved Rs 6,000 crore fund raise plan, of which Rs 3,014 crore was to be raised through preferential allotment of shares and Rs 3,000 crore share issue to institutional buyers.

Anil Ambani's flagship firm, Reliance Infrastructure Ltd is set to receive Rs 1,100 crore equity infusion from the promoters and another Rs 1,910 crore from two Mumbai-based investment firms, according to a filing by the company.